I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 6 studies | 20% ± 4% | |
| pro-B cell | 5 studies | 29% ± 9% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 19% ± 4% | |
| plasmacytoid dendritic cell | 5 studies | 23% ± 6% | |
| precursor B cell | 4 studies | 24% ± 3% | |
| conventional dendritic cell | 3 studies | 22% ± 4% | |
| fibroblast | 3 studies | 19% ± 4% | |
| epithelial cell | 3 studies | 30% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 5% | |
| basal cell | 3 studies | 18% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
